We are live on ! Find out more
NKTR icon

Nektar Therapeutics
NKTR

230 hedge funds and large institutions have $561M invested in Nektar Therapeutics in 2022 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 70 increasing their positions, 74 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

814% more call options, than puts

Call options by funds: $2M | Put options by funds: $219K

20% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 25

1% more funds holding

Funds holding: 227 → 230 (+3)

0.3% less ownership

Funds ownership: 6.53% → 6.24% (-0.3%)

5% less repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 74

19% less capital invested

Capital invested by funds: $693M → $561M (-$131M)

Holders
230
Holders Change
+3
Holders Change %
+1.32%
% of All Funds
3.96%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
30
Increased
70
Reduced
74
Closed
25
Calls
$2M
Puts
$219K
Net Calls
+$1.78M
Net Calls Change
-$1.41M

Top Buyers

1
BlackRock
BlackRock
New York
+$13.8M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$10.2M
3
Northern Trust
Northern Trust
Illinois
+$3.87M
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$3.21M
5
Federated Hermes
Federated Hermes
Pennsylvania
+$2.89M

Top Sellers

1
First Trust Advisors
First Trust Advisors
Illinois
-$29.8M
2
MC
Maverick Capital
Texas
-$12.2M
3
GPP
Great Point Partners
Connecticut
-$10.7M
4
AllianceBernstein
AllianceBernstein
Tennessee
-$4.33M
5
State Street
State Street
Massachusetts
-$3.46M
Name Holding Trade Value Shares
Change 		Change in
Stake
CA
201
Crewe Advisors
Utah
$1K – – –
First Manhattan
202
First Manhattan
New York
$1K – – –
HI
203
Harbour Investments
Wisconsin
$1K – – –
National Bank of Canada
204
National Bank of Canada
Quebec, Canada
$1K – – –
QCG
205
Quadrant Capital Group
Ohio
$1K +$178 +3 +13%
SPIA
206
Steward Partners Investment Advisory
New York
$1K +$773 +13 New
BTI
207
Blue Trust Inc
Georgia
$1K +$952 +16 +800%
APA
208
American Portfolios Advisors
New York
$736 – – –
SWA
209
Sutton Wealth Advisors
Florida
$602 +$773 +13 New
BCWM
210
Bartlett & Co Wealth Management
Ohio
$320 – – –
MG
211
MilWealth Group
Wisconsin
$317 – – –
Bank of Montreal
212
Bank of Montreal
Ontario, Canada
$168 -$923K -15,513 -82%
PWP
213
Principle Wealth Partners
Connecticut
$48 – – –
First Trust Advisors
214
First Trust Advisors
Illinois
– -$29.8M -522,303 Closed
MC
215
Maverick Capital
Texas
– -$12.2M -214,559 Closed
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
216
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
– -$2.28M -39,941 Closed
California Public Employees Retirement System
217
California Public Employees Retirement System
California
– -$1.25M -21,995 Closed
Capital Fund Management (CFM)
218
Capital Fund Management (CFM)
France
– -$784K -13,756 Closed
Voloridge Investment Management
219
Voloridge Investment Management
Florida
– -$729K -12,789 Closed
EGM
220
Engineers Gate Manager
New York
– -$330K -5,797 Closed
MSRPS
221
Maryland State Retirement & Pension System
Maryland
– -$284K -4,977 Closed
DekaBank Deutsche Girozentrale
222
DekaBank Deutsche Girozentrale
Germany
– -$239K -4,073 Closed
Qube Research & Technologies (QRT)
223
Qube Research & Technologies (QRT)
United Kingdom
– -$169K -2,965 Closed
CM
224
Capula Management
Cayman Islands
– -$82K -1,443 Closed
DU
225
Delphia (USA)
Ontario, Canada
– -$65K -1,133 Closed
6 7 8
9
10

NKTR Hedge Fund Activity: Q3 2022 in Review

230 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Nektar Therapeutics (NKTR) for Q3 2022, worth a combined $561M — down 19% from $693M a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new NKTR positions and 25 closed out — a net gain of 5 holders — while 70 added to existing stakes and 74 trimmed.

The largest buyer was BlackRock, adding an estimated $13.8M. The largest seller was First Trust Advisors, exiting entirely with an estimated $29.8M sold.

  • 230 institutional investors held Nektar Therapeutics (NKTR) as of Q3 2022, up from 227 in Q2 2022.
  • Funds reported $561M of Nektar Therapeutics stock for Q3 2022, down 19% quarter-over-quarter.
  • 30 funds opened new Nektar Therapeutics positions in Q3 2022 and 25 closed out, a net change of +5 holders.
  • The largest Nektar Therapeutics buyer in Q3 2022 was BlackRock, an estimated $13.8M added.
  • The largest Nektar Therapeutics seller in Q3 2022 was First Trust Advisors, an estimated $29.8M sold.

Based on aggregated 13F filings for Q3 2022.